openPR Logo
Press release

Anti-Venom Market by Investment Feasibility, Sales, Production, manufacturers, regions and cost structure and forecast to 2023

02-13-2019 03:25 PM CET | Health & Medicine

Press release from: Market Research Future

Anti-Venom Market

Anti-Venom Market

Anti-Venom Market Highlights

Anti-venom is a purified antibody used against venoms or venom components. In this process, animals are immunized with the venom of a snake, and then antibodies are extracted from it. Anti-venom is the only definitive treatment against snake or scorpion bites.

A number of factors such as the increasing cases of snake bites, increasing government funding, increasing patient pool, unmet medical needs, increasing awareness about antivenoms, and enhancing regulatory framework are boosting the growth of the market.

It is estimated that the anti-venom market is expected to grow at a CAGR of 6.5% during the forecast period of 2017–2023.

Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/5859

Industry Segmentation

The global anti-venom market is segmented by type, type of species, mode of action, product type, and end-user.

On the basis of type, the global anti-venom market is classified as polyvalent heterologous antivenom, monovalent heterologous antivenom, homologous antivenom, and small molecule anti-toxins.

On the basis of type of species, the global anti-venom market is classified as snakes, scorpions, spider, and others. The snake segment is further classified as common cobra, common krait, Russell viper, and others.

On the basis of mode of action, the global anti-venom market is classified as cytotoxic, neurotoxic, haemotoxic, cardiotoxic, myotoxic, and others.

On the basis of product type, the global anti-venom market is classified as snake anti-venom, scorpion anti-venom, spider anti-venom, others.

On the basis of end-user, the global anti-venom market is segmented into hospitals, clinics, ambulatory surgical centers, and others.

Competitive Analysis by Major Key Players

Some of the key players in the global anti-venom market are Allison Medical, Inc., Artsana S.p.a., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Hamilton Company, Hill-Rom, Hu-Friedy Mfg. Co., LLC, Johnson & Johnson Services, Inc, Medline Industries, Inc., Medtronic plc, Novo Nordisk A/s, Owen Mumford, Ltd., Roboz Surgical Instrument, Smiths Medical, Stryker Corporation, Terumo Corporation, Thermo Fisher Scientific, UltiMed, Inc., Ypsomed Holding AG, and others.

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/anti-venom-market-5859

Comprehensive Regional Analysis

The Americas dominates the anti-venom market owing to the increasing cases of snake bites, and scorpion bites and high healthcare expenditure.

Europe holds the second position in the anti-venom market. The financial support by the government towards research and development and improvement in the reimbursement scenario are expected to drive the European anti-venom market. According to the data suggested by Eurostat, it is observed that among the EU Member States, the highest value of healthcare expenditure was recorded in Germany in 2014 i.e. EUR 321 billion which is further followed by France with EUR 237 billion and the United Kingdom with EUR 223 billion. In 2016, the R&D expenditure in the pharmaceutical industry was EUR 35000 million, suggested by the European Federation of Pharmaceutical Industries and Association.

Asia Pacific is the fastest growing anti-venom market owing to a huge patient pool and rising advancements in pharmaceuticals. According to the Indian Brand Equity Foundation (IBEF), in 2016 the generics market of India stood at USD 26.1 billion. As per the statistics suggested by the World Health Organization (WHO), it has been estimated that around 2.8 million people are bitten by snakes and nearly 46 900 people die from snakebite every year.

The Middle East and Africa holds the lowest share of the global market due to slow development, lack of technical knowledge, and poor medical facilities.

Avail Discount at https://www.marketresearchfuture.com/check-discount/5859

Intended Audience

Pharmaceutical Companies

Research and Development (R&D) Companies

Diagnostic Laboratories

Government Research Institutes

Academic Institutes and Universities

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti-Venom Market by Investment Feasibility, Sales, Production, manufacturers, regions and cost structure and forecast to 2023 here

News-ID: 1585847 • Views:

More Releases from Market Research Future

Subsea Manifolds Market Projection: USD 4,120.53 Million in 2025 Rising to USD 6,585.15 Million by 2035 at 4% CAGR
Subsea Manifolds Market Projection: USD 4,120.53 Million in 2025 Rising to USD 6 …
The subsea manifolds market plays a critical role in modern offshore oil and gas production by enabling efficient control, distribution, and monitoring of hydrocarbons on the seabed. Subsea manifolds act as gathering points that connect multiple wells to production systems, allowing operators to optimize flow management, reduce infrastructure complexity, and improve overall field performance. As offshore exploration moves into deeper waters and more technically challenging environments, subsea manifolds have become
Military Cybersecurity Market 2026: Innovation, AI Defense, and Strategic Demand
Military Cybersecurity Market 2026: Innovation, AI Defense, and Strategic Demand
In an era defined by rapidly evolving cyber threats and digital warfare, the Military Cybersecurity industry is undergoing a fundamental transformation. As nation-states, defense organizations, and allied forces expand their reliance on digital networks, unmanned systems, IoT-enabled platforms, and cloud infrastructures, securing military cyberspace has become a strategic priority. The shifting threat landscape is driving unprecedented demand for advanced cybersecurity solutions that can protect critical defense assets, ensure operational continuity,
Drone Identification Market Thriving Worldwide industry with AI by 78.23 USD Billion- 2035 | Trend, Demand, Regional Analysis
Drone Identification Market Thriving Worldwide industry with AI by 78.23 USD Bil …
The Drone Identification Market is gaining significant traction in 2026 as unmanned aerial systems (UAS) become more widespread across commercial, governmental, and recreational applications. With drone usage expanding rapidly, there is a pressing need for effective identification, tracking, and management systems that ensure airspace safety, regulatory compliance, and coordinated operations. This demand is driving investment in advanced technologies and solutions that support remote identification, situational awareness, and secure communications within
Healthcare BPO Market to Reach USD 972.65 Billion by 2035, Expanding at 4.22% CAGR | MRFR
Healthcare BPO Market to Reach USD 972.65 Billion by 2035, Expanding at 4.22% CA …
The Healthcare BPO (Business Process Outsourcing) Market is experiencing significant growth as healthcare providers increasingly outsource non-core functions to specialized service providers. Healthcare BPO services include medical billing and coding, claims processing, customer care, revenue cycle management, IT support, telehealth support, transcription services, and other administrative functions. Outsourcing enables healthcare organizations to reduce operational costs, improve process efficiency, and focus on core clinical services. Market Overview and Growth Trends As per Market

All 5 Releases


More Releases for EUR

Contec S.A. raises EUR 10 million from investor
Contec S.A., a startup recovering industrial raw materials from used tires, has raised EUR 10 million in their latest funding round. These funds will be used to expand the efficiency of Contec's plant (Szczecin, Poland) almost threefold. Two investors are providing the funds: HiTech ASI, the corporate venture capital fund of Bank Gospodarstwa Krajowego, and the Warsaw Equity Group, which is the majority shareholder. Contec S.A. invests in increasing processing
EUR 155,000 for Safe Zones Project
Eichsfeld Festival Attracts 25,000 Music Fans to Downtown Duderstadt "Tonight is going to rock!" It was with these words that initiators Professor Hans Georg Näder and Peter Maffay opened the 2012 Eichsfeld Festival this past Saturday. Around 25,000 music fans followed the invitation to experience top-class live performances in the Marktstraße of Duderstadt that day. Peter Maffay, Ich + Ich and four regional special guests did more than just wow the
Clariant successfully issues EUR 500 million Eurobond
Muttenz, January 17, 2012 – Today, Clariant successfully priced an Eurobond transaction of EUR 500 million with a tenor of 5 years, issued by Clariant Finance (Luxembourg) S.A. and guaranteed by Clariant Ltd. The fixed rate notes with a minimum denomination of EUR 100,000 and a final coupon of 5 ⅝ % p.a. are maturing on January 24, 2017. The orderbook was significantly oversubscribed on the back of strong investor demand.
VSCloud – cloud services from 0.78 EUR per day
On 15th of August, at a press conference, the unique cloud project named VSCloud was presented which provides cloud services of IaaS (Infrastructure as a Service) type. After three months, VSCloud can boast with hundreds of active users mainly from the Czech Republic and Slovakia. The leadership of VSCloud foresees that the number of first thousand active users will be surpassed by the end of this year. What are the advantages
euNetworks Reports 26% Revenue Rise to EUR 21.7M
London, United Kingdom - 12 November 2009 - euNetworks Group Limited, (SGX: H23.SI), a provider of mission-critical, high-performance networking solutions in Europe, reports a 26% rise in revenue for the nine months ended 30 September 2009 (“9M09”) to €21.7 million, from €17.2 million reported in the corresponding period a year ago (“9M08”). In line with the Group’s efforts at improving its operational efficiencies, gross margin also improved from 42%
AXIGEN Announces 2 Million EUR Investment
Bucharest, November 14th, 2007 – Gecad Technologies, AXIGEN Mail Server developer (axigen.com) announces today the first round of investment from a consortium of important venture capitals and technology companies such as Global Finance, 3TS-Cisco Growth Fund III and others. The investment amounted to 2 million euro and is equivalent to 11.76% of the Gecad Technologies/AXIGEN shares. “This is the first wave of investment in AXIGEN subsequently targeting an Initial Public Offering